Cynthia B. Wang, MD
Dermatology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Wang’s office at (408) 851-1000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A82128 · Current
Licensed to practise in California · since 2003 · expires 2027-02-28 · New York University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$146,584
Pharmacies billed $146,584 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 356) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
298 generic and 58 brand-name prescriptions · $146,584 in drug cost · 21 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Otezla | 17 | $75,542 | $4,444 |
| Cosentyx Sensoready (2 Pens) | 12 | $26,554 | $2,213 |
| Fluorouracil | 65 | $3,065 | $47 |
| Mometasone Furoate | 15 | $956 | $64 |
| Retin-A | 13 | $563 | $43 |
See all 10 drugs
| Otezla | 17 | $75,542 | $4,444 |
| Cosentyx Sensoready (2 Pens) | 12 | $26,554 | $2,213 |
| Fluorouracil | 65 | $3,065 | $47 |
| Mometasone Furoate | 15 | $956 | $64 |
| Retin-A | 13 | $563 | $43 |
| Triamcinolone Acetonide | 31 | $497 | $16 |
| Clobetasol Propionate | 19 | $457 | $24 |
| Metronidazole | 21 | $452 | $22 |
| Fluocinonide | 26 | $397 | $15 |
| Mupirocin | 20 | $206 | $10 |
Year by year
| 2024 | 356 | 155 | 0% (0) | 16% | $146,584 |
| 2023 | 373 | 168 | 0% (0) | 14% | $109,648 |
| 2022 | 389 | 171 | 0% (0) | 12% | $102,345 |
| 2021 | 310 | 129 | 0% (0) | 18% | $159,561 |
| 2020 | 259 | 110 | 0% (0) | 13% | $65,104 |
| 2019 | 272 | 123 | 0% (0) | 22% | $76,813 |
| 2018 | 250 | 120 | 0% (0) | 24% | $98,038 |
| 2017 | 422 | 174 | 0% (0) | 30% | $201,695 |
| 2016 | 393 | 181 | 0% (0) | 34% | $120,999 |
| 2015 | 376 | 185 | 0% (0) | 20% | $83,840 |
| 2014 | 417 | 204 | None | None | $119,938 |
| 2013 | 349 | 170 | 0% (0) | 22% | $55,909 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Otezla | 13 | $55,145 | $4,242 |
| Cosentyx Sensoready (2 Pens) | 15 | $41,345 | $2,756 |
| Tacrolimus | 24 | $3,335 | $139 |
| Fluorouracil | 50 | $2,389 | $48 |
| Clobetasol Propionate | 34 | $756 | $22 |
| Triamcinolone Acetonide | 31 | $597 | $19 |
| Fluocinonide | 18 | $583 | $32 |
| Metronidazole | 19 | $475 | $25 |
| Mupirocin | 27 | $353 | $13 |
| Retin-A | 11 | $306 | $28 |
| Prednisone | 15 | $251 | $17 |
| Cephalexin | 11 | $119 | $11 |
| Terbinafine | 12 | $68 | $6 |
2022: 10 drugs
| Otezla | 13 | $49,362 | $3,797 |
| Cosentyx Pen (2 Pens) | 13 | $26,372 | $2,029 |
| Tacrolimus | 23 | $4,785 | $208 |
| Fluorouracil | 66 | $4,015 | $61 |
| Clobetasol Propionate | 44 | $2,163 | $49 |
| Betamethasone Diprop Augmented | 17 | $964 | $57 |
| Alclometasone Dipropionate | 12 | $615 | $51 |
| Fluocinonide | 15 | $566 | $38 |
| Triamcinolone Acetonide | 29 | $405 | $14 |
| Mupirocin | 21 | $334 | $16 |
2021: 10 drugs
| Humira | 13 | $54,964 | $4,228 |
| Otezla | 14 | $48,635 | $3,474 |
| Fluorouracil | 49 | $3,133 | $64 |
| Clobetasol Propionate | 31 | $2,197 | $71 |
| Betamethasone Diprop Augmented | 17 | $1,591 | $94 |
| Fluocinonide | 26 | $1,430 | $55 |
| Triamcinolone Acetonide | 38 | $738 | $19 |
| Alclometasone Dipropionate | 11 | $711 | $65 |
| Selenium Sulfide | 12 | $271 | $23 |
| Mupirocin | 12 | $186 | $16 |
2020: 7 drugs
| Humira | 12 | $49,737 | $4,145 |
| Fluorouracil | 31 | $2,193 | $71 |
| Betamethasone Diprop Augmented | 22 | $1,735 | $79 |
| Fluocinonide | 19 | $1,683 | $89 |
| Clobetasol Propionate | 25 | $1,663 | $67 |
| Hydroxychloroquine Sulfate | 14 | $576 | $41 |
| Triamcinolone Acetonide | 28 | $520 | $19 |
2019: 6 drugs
| Humira | 12 | $48,596 | $4,050 |
| Fluorouracil | 39 | $3,111 | $80 |
| Fluocinonide | 24 | $2,557 | $107 |
| Clobetasol Propionate | 14 | $1,929 | $138 |
| Triamcinolone Acetonide | 33 | $599 | $18 |
| Retin-A | 11 | $477 | $43 |
2018: 7 drugs
| Clobetasol Propionate | 15 | $9,344 | $623 |
| Fluorouracil | 39 | $6,882 | $176 |
| Fluocinonide | 25 | $2,567 | $103 |
| Betamethasone Diprop Augmented | 17 | $2,347 | $138 |
| Triamcinolone Acetonide | 24 | $1,779 | $74 |
| Vectical | 11 | $1,264 | $115 |
| Terbinafine | 11 | $64 | $6 |
2017: 13 drugs
| Humira | 14 | $51,851 | $3,704 |
| Fluorouracil | 53 | $8,319 | $157 |
| Acitretin | 11 | $6,054 | $550 |
| Betamethasone Dipropionate | 38 | $5,654 | $149 |
| Fluocinonide | 33 | $3,488 | $106 |
| Metronidazole | 14 | $1,696 | $121 |
| Clobetasol Propionate | 11 | $1,637 | $149 |
| Vectical | 14 | $1,481 | $106 |
| Triamcinolone Acetonide | 31 | $792 | $26 |
| Mometasone Furoate | 17 | $577 | $34 |
| Retin-A | 12 | $420 | $35 |
| Hydrocortisone | 16 | $291 | $18 |
| Terbinafine | 12 | $77 | $6 |
2016: 14 drugs
| Humira | 13 | $43,666 | $3,359 |
| Fluorouracil | 61 | $10,048 | $165 |
| Betamethasone Dipropionate | 31 | $4,780 | $154 |
| Clobetasol Propionate | 14 | $3,007 | $215 |
| Fluocinonide | 25 | $2,969 | $119 |
| Metronidazole | 18 | $2,176 | $121 |
| Vectical | 12 | $1,269 | $106 |
| Retin-A | 20 | $1,182 | $59 |
| Alclometasone Dipropionate | 13 | $1,031 | $79 |
| Triamcinolone Acetonide | 41 | $965 | $24 |
| Mometasone Furoate | 13 | $566 | $44 |
| Doxycycline Monohydrate | 15 | $543 | $36 |
| Mupirocin | 11 | $267 | $24 |
| Prednisone | 14 | $205 | $15 |
2015: 10 drugs
| Humira | 11 | $28,845 | $2,622 |
| Fluorouracil | 66 | $9,964 | $151 |
| Clobetasol Propionate | 22 | $7,060 | $321 |
| Fluocinonide | 24 | $2,587 | $108 |
| Metronidazole | 19 | $1,666 | $88 |
| Vectical | 12 | $1,370 | $114 |
| Triamcinolone Acetonide | 45 | $1,275 | $28 |
| Retin-A | 16 | $839 | $52 |
| Mupirocin | 12 | $361 | $30 |
| Hydrocortisone | 16 | $326 | $20 |
2014: 10 drugs
| Enbrel | 15 | $65,715 | $4,381 |
| Fluorouracil | 59 | $9,015 | $153 |
| Protopic | 11 | $4,713 | $428 |
| Metronidazole | 28 | $2,770 | $99 |
| Clobetasol Propionate | 33 | $1,839 | $56 |
| Fluocinonide | 38 | $1,768 | $47 |
| Triamcinolone Acetonide | 42 | $1,652 | $39 |
| Vectical | 11 | $1,185 | $108 |
| Mometasone Furoate | 19 | $1,083 | $57 |
| Retin-A | 11 | $339 | $31 |
2013: 7 drugs
| Fluorouracil | 51 | $9,907 | $194 |
| Protopic | 11 | $4,237 | $385 |
| Metronidazole | 14 | $2,239 | $160 |
| Triamcinolone Acetonide | 64 | $2,202 | $34 |
| Clobetasol Propionate | 30 | $1,964 | $65 |
| Fluocinonide | 43 | $1,520 | $35 |
| Mupirocin | 11 | $442 | $40 |
Money from drug and device companies
$348 in 2023
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Cosentyx | $215 | 2 payments
|
| Arcutis Biotherapeutics | None | $132 | 1 payment
|
See all 3 published payments
| Arcutis Biotherapeutics | Meals · 2023-12-12 | None | $132 |
| Novartis Pharmaceuticals | Meals · 2023-06-06 | Cosentyx | $92 |
| Novartis Pharmaceuticals | Meals · 2023-02-24 | Cosentyx | $124 |
Professional record
- NPI
- 1063599918
- Licence
- CA A82128California A82128: Current · expires 2027-02-28
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A821280
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2006-10-31
- NPI last updated
- 2021-12-09
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.